iGMDRD376
Canonical SMILES: CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl
InChI: InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)
InChI Key: SPMVMDHWKHCIDT-UHFFFAOYSA-N
Drug Class:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBenzene DerivativesHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicProtein Kinase InhibitorsReceptors, Vascular Endothelial Growth Factor, antagonists & inhibitorsUreaDrug Pathways:
RTK signalingDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Tivozanib
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |